246 related articles for article (PubMed ID: 21398039)
1. Influence from genetic variability on opioid use for cancer pain: a European genetic association study of 2294 cancer pain patients.
Klepstad P; Fladvad T; Skorpen F; Bjordal K; Caraceni A; Dale O; Davies A; Kloke M; Lundström S; Maltoni M; Radbruch L; Sabatowski R; Sigurdardottir V; Strasser F; Fayers PM; Kaasa S;
Pain; 2011 May; 152(5):1139-1145. PubMed ID: 21398039
[TBL] [Abstract][Full Text] [Related]
2. Clinical and genetic factors associated with nausea and vomiting in cancer patients receiving opioids.
Laugsand EA; Fladvad T; Skorpen F; Maltoni M; Kaasa S; Fayers P; Klepstad P
Eur J Cancer; 2011 Jul; 47(11):1682-91. PubMed ID: 21570824
[TBL] [Abstract][Full Text] [Related]
3. Lack of association between genetic variability and multiple pain-related outcomes in a large cohort of patients with advanced cancer: the European Pharmacogenetic Opioid Study (EPOS).
Fladvad T; Fayers P; Skorpen F; Kaasa S; Klepstad P
BMJ Support Palliat Care; 2012 Dec; 2(4):351-5. PubMed ID: 24654220
[TBL] [Abstract][Full Text] [Related]
4. Genetic variation and cognitive dysfunction in opioid-treated patients with cancer.
Kurita GP; Ekholm O; Kaasa S; Klepstad P; Skorpen F; Sjøgren P
Brain Behav; 2016 Jul; 6(7):e00471. PubMed ID: 27247849
[TBL] [Abstract][Full Text] [Related]
5. Can variability in the effect of opioids on refractory breathlessness be explained by genetic factors?
Currow DC; Quinn S; Ekstrom M; Kaasa S; Johnson MJ; Somogyi AA; Klepstad P
BMJ Open; 2015 May; 5(5):e006818. PubMed ID: 25948405
[TBL] [Abstract][Full Text] [Related]
6. The genetic influences on oxycodone response characteristics in human experimental pain.
Olesen AE; Sato H; Nielsen LM; Staahl C; Droney J; Gretton S; Branford R; Drewes AM; Arendt-Nielsen L; Riley J; Ross J
Fundam Clin Pharmacol; 2015 Aug; 29(4):417-25. PubMed ID: 26042474
[TBL] [Abstract][Full Text] [Related]
7. Genetic Influences of OPRM1, OPRD1 and COMT on Morphine Analgesia in a Multi-Modal, Multi-Tissue Human Experimental Pain Model.
Nielsen LM; Christrup LL; Sato H; Drewes AM; Olesen AE
Basic Clin Pharmacol Toxicol; 2017 Jul; 121(1):6-12. PubMed ID: 28084056
[TBL] [Abstract][Full Text] [Related]
8. Genetic and Non-genetic Factors Associated With Constipation in Cancer Patients Receiving Opioids.
Laugsand EA; Skorpen F; Kaasa S; Sabatowski R; Strasser F; Fayers P; Klepstad P
Clin Transl Gastroenterol; 2015 Jun; 6(6):e90. PubMed ID: 26087058
[TBL] [Abstract][Full Text] [Related]
9. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
10. Modelling the PKPD of oxycodone in experimental pain - Impact of opioid receptor polymorphisms.
Olsen R; Foster DJ; Upton RN; Olesen AE; Ross JR; Droney J; Sato H; Drewes AM; Kreilgaard M
Eur J Pharm Sci; 2016 Apr; 86():41-9. PubMed ID: 26946441
[TBL] [Abstract][Full Text] [Related]
11. Association of polymorphisms in pharmacogenetic candidate genes (OPRD1, GAL, ABCB1, OPRM1) with opioid dependence in European population: a case-control study.
Beer B; Erb R; Pavlic M; Ulmer H; Giacomuzzi S; Riemer Y; Oberacher H
PLoS One; 2013; 8(9):e75359. PubMed ID: 24086514
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide association study of therapeutic opioid dosing identifies a novel locus upstream of OPRM1.
Smith AH; Jensen KP; Li J; Nunez Y; Farrer LA; Hakonarson H; Cook-Sather SD; Kranzler HR; Gelernter J
Mol Psychiatry; 2017 Mar; 22(3):346-352. PubMed ID: 28115739
[TBL] [Abstract][Full Text] [Related]
13. Analgesia and central side-effects: two separate dimensions of morphine response.
Droney JM; Gretton SK; Sato H; Ross JR; Branford R; Welsh KI; Cookson W; Riley J
Br J Clin Pharmacol; 2013 May; 75(5):1340-50. PubMed ID: 23072578
[TBL] [Abstract][Full Text] [Related]
14. A review of the role of genetic testing in pain medicine.
Trescot AM; Faynboym S
Pain Physician; 2014; 17(5):425-45. PubMed ID: 25247900
[TBL] [Abstract][Full Text] [Related]
15. Genetic Factors Associated With Pain Severity, Daily Opioid Dose Requirement, and Pain Response Among Advanced Cancer Patients Receiving Supportive Care.
Yennurajalingam S; Astolfi A; Indio V; Beccaro M; Schipani A; Yu R; Shete S; Reyes-Gibby C; Lu Z; Williams JL; Yeun SC; Anderson AE; Biasco G; Bruera E
J Pain Symptom Manage; 2021 Oct; 62(4):785-795. PubMed ID: 33848569
[TBL] [Abstract][Full Text] [Related]
16. Innate Immune Signalling Genetics of Pain, Cognitive Dysfunction and Sickness Symptoms in Cancer Pain Patients Treated with Transdermal Fentanyl.
Barratt DT; Klepstad P; Dale O; Kaasa S; Somogyi AA
PLoS One; 2015; 10(9):e0137179. PubMed ID: 26332828
[TBL] [Abstract][Full Text] [Related]
17. Candidate gene analyses for acute pain and morphine analgesia after pediatric day surgery: African American versus European Caucasian ancestry and dose prediction limits.
Li J; Wei Z; Zhang J; Hakonarson H; Cook-Sather SD
Pharmacogenomics J; 2019 Dec; 19(6):570-581. PubMed ID: 30760877
[TBL] [Abstract][Full Text] [Related]
18. A GTP cyclohydrolase 1 genetic variant delays cancer pain.
Lötsch J; Klepstad P; Doehring A; Dale O
Pain; 2010 Jan; 148(1):103-106. PubMed ID: 19959292
[TBL] [Abstract][Full Text] [Related]
19. OPRM1 influence on and effectiveness of an individualized treatment plan for prescription opioid use disorder patients.
Muriel J; Margarit C; Planelles B; Serralta MJ; Puga C; Inda MD; Cutillas E; Morales D; Horga JF; Peiró AM
Ann N Y Acad Sci; 2018 Aug; 1425(1):82-93. PubMed ID: 29781244
[TBL] [Abstract][Full Text] [Related]
20. Cross-sectional analysis of the influence of currently known pharmacogenetic modulators on opioid therapy in outpatient pain centers.
Lötsch J; von Hentig N; Freynhagen R; Griessinger N; Zimmermann M; Doehring A; Rohrbacher M; Sittl R; Geisslinger G
Pharmacogenet Genomics; 2009 Jun; 19(6):429-36. PubMed ID: 19514130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
